Saturday 4 April 2015

Cancer Diagnostic Company Foundation Medicine Stockholders Approve Pending Roche Transaction

Cancer diagnostic company Foundation Medicine has announced that its stockholders approved each proposal in connection with the pending strategic transaction with Swiss drug maker Roche presented at the meeting held on April 2, 2015. Around 80% of the total outstanding shares of common stock eligible to vote at the meeting were voted in favor of each proposal related to the Roche transaction. The approval of these proposals satisfies one of the remaining ...

via Medindia Health News More READ

No comments:

Post a Comment